Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(1)
About
Eris Lifesciences Ltd.
NSE: ERIS
|
BSE: 540596
|
ISIN: INE406M01024
|
Industry: Pharmaceuticals
|
Expensive Performer
1479.7000
34.90
(
2.42
%)
NSE
May 14, 2025
15:18 PM
81.37% Gain from 52W Low
Volume:
137.1K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Eris Lifesciences Ltd.
07 Aug 2023
1479.70
2.42%
Eris Lifesciences (BUY): In-line quarter; margins moving back on track
Buy:
Eris Lifesciences Ltd.
by
BOB Capital Markets Ltd.
Target: 955
Target
BOB Capital Markets Ltd.
Q1 revenue/PAT in line but operating margin ahead of consensus at 36.4% (+395bps YoY)
Eris Lifesciences Ltd. has an
average target
of 1379.33 from 3 brokers.
More from Eris Lifesciences Ltd.
Recommended
Market trades higher, Garden Reach's Q4 revenue beats Forecaster estimates by 33.3%,
Trendlyne Marketwatch |
14 May 2025, 03:08PM
Chart of the week: From partnerships to diversification: Dixon Technologies powers ahead to new highs
The Baseline |
14 May 2025, 09:48AM
Earnings Call Transcript - Q1FY21 for Eris Lifesciences
|
04 Aug 2020